Microglia and the aging brain: are senescent microglia the key to neurodegeneration?

DM Angelova, DR Brown - Journal of Neurochemistry, 2019 - Wiley Online Library
The single largest risk factor for etiology of neurodegenerative diseases like Alzheimer's
disease is increased age. Therefore, understanding the changes that occur as a result of …

Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration

D Kempuraj, R Thangavel, GP Selvakumar… - Frontiers in cellular …, 2017 - frontiersin.org
Neuroinflammatory response is primarily a protective mechanism in the brain. However,
excessive and chronic inflammatory responses can lead to deleterious effects involving …

The role of oxidative stress in Parkinson's disease

V Dias, E Junn, MM Mouradian - Journal of Parkinson's …, 2013 - content.iospress.com
Oxidative stress plays an important role in the degeneration of dopaminergic neurons in
Parkinson's disease (PD). Disruptions in the physiologic maintenance of the redox potential …

Microglia in Parkinson's disease

MS Ho - Neuroglia in neurodegenerative diseases, 2019 - Springer
Microglia are the most abundant immune cells in the central nervous system (CNS), where
they interact with neurons and exhibit a wide array of functions in physiological and …

Targeting microglial activation states as a therapeutic avenue in Parkinson's disease

SR Subramaniam, HJ Federoff - Frontiers in aging neuroscience, 2017 - frontiersin.org
Parkinson's disease (PD) is a chronic and progressive disorder characterized
neuropathologically by loss of dopamine neurons in the substantia nigra, intracellular …

Therapeutic potential of vital transcription factors in Alzheimer's and Parkinson's disease with particular emphasis on transcription factor EB mediated autophagy

SN Rai, N Tiwari, P Singh, D Mishra, AK Singh… - Frontiers in …, 2021 - frontiersin.org
Autophagy is an important cellular self-digestion and recycling pathway that helps in
maintaining cellular homeostasis. Dysregulation at various steps of the autophagic and …

Progress and challenges in targeted protein degradation for neurodegenerative disease therapy

Y Fang, J Wang, M Zhao, Q Zheng, C Ren… - Journal of Medicinal …, 2022 - ACS Publications
Neurodegenerative diseases (NDs) are currently incurable diseases that cause progressive
degeneration of nerve cells. Many of the disease-causing proteins of NDs are “undruggable” …

Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives

T Behl, G Kaur, A Sehgal, S Bhardwaj, S Singh… - International Journal of …, 2021 - mdpi.com
Neurodegeneration is the pathological condition, in which the nervous system or neuron
loses its structure, function, or both, leading to progressive degeneration or the death of …

Insulin resistance and Parkinson's disease: a new target for disease modification?

D Athauda, T Foltynie - Progress in neurobiology, 2016 - Elsevier
There is growing evidence that patients with Type 2 diabetes have an increased risk of
developing Parkinson's disease and share similar dysregulated pathways suggesting …

Triggering of inflammasome by aggregated α–synuclein, an inflammatory response in synucleinopathies

G Codolo, N Plotegher, T Pozzobon, M Brucale… - PloS one, 2013 - journals.plos.org
Parkinson's disease (PD) is one of the most common neurodegenerative diseases. It is
characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta of …